Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 9
2006 5
2007 2
2008 3
2009 4
2010 1
2011 2
2012 2
2013 1
2014 1
2015 1
2017 3
2018 2
2019 2
2020 6
2021 2
2022 6
2023 8
2024 5
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Free article. Clinical Trial.
Systemic treatment of gastric cancer.
Morabito A, Carillio G, Longo R. Morabito A, et al. Among authors: longo r. Crit Rev Oncol Hematol. 2009 Jun;70(3):216-34. doi: 10.1016/j.critrevonc.2008.08.005. Epub 2008 Oct 1. Crit Rev Oncol Hematol. 2009. PMID: 18829344 Review.
Targeted therapy of breast cancer.
Longo R, Torino F, Gasparini G. Longo R, et al. Curr Pharm Des. 2007;13(5):497-517. doi: 10.2174/138161207780162890. Curr Pharm Des. 2007. PMID: 17348846 Review.
The paradigm of personalized therapy in oncology.
Gasparini G, Longo R. Gasparini G, et al. Among authors: longo r. Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S7-16. doi: 10.1517/14728222.2011.637921. Epub 2011 Nov 11. Expert Opin Ther Targets. 2012. PMID: 22073968 Review.
Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report.
Cezar M, Belletto R, Polidori S, Soive L, Campitiello M, Legros PO, Egea J, Plastino F, Benaiteau M, Tyvaert L, Tortora G, Longo R. Cezar M, et al. Among authors: longo r. BMC Neurol. 2025 Nov 14;25(1):467. doi: 10.1186/s12883-025-04483-z. BMC Neurol. 2025. PMID: 41239244 Free PMC article.
Is tailored therapy feasible in oncology?
Gasparini G, Longo R, Torino F, Gattuso D, Morabito A, Toffoli G. Gasparini G, et al. Among authors: longo r. Crit Rev Oncol Hematol. 2006 Jan;57(1):79-101. doi: 10.1016/j.critrevonc.2005.07.003. Epub 2005 Dec 7. Crit Rev Oncol Hematol. 2006. PMID: 16337806 Review.
77 results